APO Research
Talk to an analyst

APO RESEARCH · REPORT

Clotting Factors Ⅷ

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Clotting Factors Ⅷ Market Outlook and Growth Opportunities 2026

23 December 2025190 pages

Choose your research edition.

Industry ResearchClotting Factors Ⅷ Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Clotting Factors Ⅷ Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Clotting Factors Ⅷ Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Clotting Factors Ⅷ Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Clotting Factors Ⅷ Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Clotting Factors Ⅷ market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Clotting Factors Ⅷ is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Clotting Factors Ⅷ is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Clotting Factors Ⅷ is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Clotting Factors Ⅷ market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Clotting Factors Ⅷ market include Taibang Biological, Shanghai Laishi, Lvshizi and Hualan Biological, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Clotting Factors Ⅷ market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Clotting Factors Ⅷ and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Clotting Factors Ⅷ sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Clotting Factors Ⅷ market size, projected growth trends, production technologies, key applications, and end-use industries.

Clotting Factors Ⅷ Segment by Company

Taibang Biological

Shanghai Laishi

Lvshizi

Hualan Biological

Clotting Factors Ⅷ Segment by Type

Injection

Freeze-dried Injection

Clotting Factors Ⅷ Segment by Application

Hemophilia A

Bleeding Diseases

Clotting Factors Ⅷ Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Clotting Factors Ⅷ status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Clotting Factors Ⅷ market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Clotting Factors Ⅷ significant trends, drivers, influence factors in global and regions.

6. To analyze Clotting Factors Ⅷ competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clotting Factors Ⅷ market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Clotting Factors Ⅷ and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clotting Factors Ⅷ.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Clotting Factors Ⅷ market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Clotting Factors Ⅷ industry.

Chapter 3: Detailed analysis of Clotting Factors Ⅷ manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Clotting Factors Ⅷ in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Clotting Factors Ⅷ in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Clotting Factors Ⅷ Industry Trends Table 2. Clotting Factors Ⅷ Industry Drivers Table 3. Clotting Factors Ⅷ Industry Opportunities and Challenges Table 4. Clotting Factors Ⅷ Industry Restraints Table 5. Global Clotting Factors Ⅷ Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Clotting Factors Ⅷ Revenue Share by Company (2021-2026) Table 7. Global Clotting Factors Ⅷ Sales Volume by Company (k units) & (2021-2026) Table 8. Global Clotting Factors Ⅷ Sales Volume Share by Company (2021-2026) Table 9. Global Clotting Factors Ⅷ Average Price (US$/unit) of Company (2021-2026) Table 10. Global Clotting Factors Ⅷ Company Ranking, (2024-2026) & (USD Million) Table 11. Global Clotting Factors Ⅷ Key Company Manufacturing Base & Headquarters Table 12. Global Clotting Factors Ⅷ Company, Product Type & Application Table 13. Global Clotting Factors Ⅷ Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Clotting Factors Ⅷ by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Freeze-dried Injection Table 19. Global Clotting Factors Ⅷ Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Clotting Factors Ⅷ Sales Volume by Type (2021-2026) & (k units) Table 21. Global Clotting Factors Ⅷ Sales Volume by Type (2027-2032) & (k units) Table 22. Global Clotting Factors Ⅷ Sales Volume Share by Type (2021-2026) Table 23. Global Clotting Factors Ⅷ Sales Volume Share by Type (2027-2032) Table 24. Global Clotting Factors Ⅷ Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Clotting Factors Ⅷ Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Clotting Factors Ⅷ Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Clotting Factors Ⅷ Sales Value Share by Type (2021-2026) Table 28. Global Clotting Factors Ⅷ Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hemophilia A Table 30. Significant Companies of Bleeding Diseases Table 31. Global Clotting Factors Ⅷ Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Clotting Factors Ⅷ Sales Volume by Application (2021-2026) & (k units) Table 33. Global Clotting Factors Ⅷ Sales Volume by Application (2027-2032) & (k units) Table 34. Global Clotting Factors Ⅷ Sales Volume Share by Application (2021-2026) Table 35. Global Clotting Factors Ⅷ Sales Volume Share by Application (2027-2032) Table 36. Global Clotting Factors Ⅷ Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Clotting Factors Ⅷ Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Clotting Factors Ⅷ Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Clotting Factors Ⅷ Sales Value Share by Application (2021-2026) Table 40. Global Clotting Factors Ⅷ Sales Value Share by Application (2027-2032) Table 41. Global Clotting Factors Ⅷ Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Clotting Factors Ⅷ Sales by Region (2021-2026) & (k units) Table 43. Global Clotting Factors Ⅷ Sales Market Share by Region (2021-2026) Table 44. Global Clotting Factors Ⅷ Sales by Region (2027-2032) & (k units) Table 45. Global Clotting Factors Ⅷ Sales Market Share by Region (2027-2032) Table 46. Global Clotting Factors Ⅷ Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Clotting Factors Ⅷ Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Clotting Factors Ⅷ Sales Value Share by Region (2021-2026) Table 49. Global Clotting Factors Ⅷ Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Clotting Factors Ⅷ Sales Value Share by Region (2027-2032) Table 51. Global Clotting Factors Ⅷ Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Clotting Factors Ⅷ Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Clotting Factors Ⅷ Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Clotting Factors Ⅷ Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Clotting Factors Ⅷ Sales by Country (2021-2026) & (k units) Table 56. Global Clotting Factors Ⅷ Sales Market Share by Country (2021-2026) Table 57. Global Clotting Factors Ⅷ Sales by Country (2027-2032) & (k units) Table 58. Global Clotting Factors Ⅷ Sales Market Share by Country (2027-2032) Table 59. Global Clotting Factors Ⅷ Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Clotting Factors Ⅷ Sales Value Market Share by Country (2021-2026) Table 61. Global Clotting Factors Ⅷ Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Clotting Factors Ⅷ Sales Value Market Share by Country (2027-2032) Table 63. Taibang Biological Company Information Table 64. Taibang Biological Business Overview Table 65. Taibang Biological Clotting Factors Ⅷ Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Taibang Biological Clotting Factors Ⅷ Product Portfolio Table 67. Taibang Biological Recent Development Table 68. Shanghai Laishi Company Information Table 69. Shanghai Laishi Business Overview Table 70. Shanghai Laishi Clotting Factors Ⅷ Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Shanghai Laishi Clotting Factors Ⅷ Product Portfolio Table 72. Shanghai Laishi Recent Development Table 73. Lvshizi Company Information Table 74. Lvshizi Business Overview Table 75. Lvshizi Clotting Factors Ⅷ Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Lvshizi Clotting Factors Ⅷ Product Portfolio Table 77. Lvshizi Recent Development Table 78. Hualan Biological Company Information Table 79. Hualan Biological Business Overview Table 80. Hualan Biological Clotting Factors Ⅷ Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Hualan Biological Clotting Factors Ⅷ Product Portfolio Table 82. Hualan Biological Recent Development Table 83. Key Raw Materials Table 84. Raw Materials Key Suppliers Table 85. Clotting Factors Ⅷ Distributors List Table 86. Clotting Factors Ⅷ Customers List Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Clotting Factors Ⅷ Product Image Figure 2. Global Clotting Factors Ⅷ Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Clotting Factors Ⅷ Sales Value (2021-2032) & (US$ Million) Figure 4. Global Clotting Factors Ⅷ Sales (2021-2032) & (k units) Figure 5. Global Clotting Factors Ⅷ Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Clotting Factors Ⅷ Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Freeze-dried Injection Image Figure 11. Global Clotting Factors Ⅷ Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Clotting Factors Ⅷ Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Clotting Factors Ⅷ Sales Volume Share by Type (2021-2032) Figure 14. Global Clotting Factors Ⅷ Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Clotting Factors Ⅷ Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Clotting Factors Ⅷ Sales Value Share by Type (2021-2032) Figure 17. Hemophilia A Image Figure 18. Bleeding Diseases Image Figure 19. Global Clotting Factors Ⅷ Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Clotting Factors Ⅷ Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Clotting Factors Ⅷ Sales Volume Share by Application (2021-2032) Figure 22. Global Clotting Factors Ⅷ Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Clotting Factors Ⅷ Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Clotting Factors Ⅷ Sales Value Share by Application (2021-2032) Figure 25. Global Clotting Factors Ⅷ Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Clotting Factors Ⅷ Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Clotting Factors Ⅷ Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Clotting Factors Ⅷ Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Clotting Factors Ⅷ Sales Value (2021-2032) & (US$ Million) Figure 30. North America Clotting Factors Ⅷ Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Clotting Factors Ⅷ Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Clotting Factors Ⅷ Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Clotting Factors Ⅷ Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Clotting Factors Ⅷ Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Clotting Factors Ⅷ Sales Value (2021-2032) & (US$ Million) Figure 36. South America Clotting Factors Ⅷ Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Clotting Factors Ⅷ Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Clotting Factors Ⅷ Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Clotting Factors Ⅷ Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Clotting Factors Ⅷ Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Freeze-dried Injection
Applications
  • Hemophilia A
  • Bleeding Diseases
Companies covered
  • Taibang Biological
  • Shanghai Laishi
  • Lvshizi
  • Hualan Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Clotting Factors Ⅷ Sales Value (2021-2032)
  4. 1.2.2 Global Clotting Factors Ⅷ Sales Volume (2021-2032)
  5. 1.2.3 Global Clotting Factors Ⅷ Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Clotting Factors Ⅷ Market Dynamics
  1. 2.1 Clotting Factors Ⅷ Industry Trends
  2. 2.2 Clotting Factors Ⅷ Industry Drivers
  3. 2.3 Clotting Factors Ⅷ Industry Opportunities and Challenges
  4. 2.4 Clotting Factors Ⅷ Industry Restraints
3 Clotting Factors Ⅷ Market by Company
  1. 3.1 Global Clotting Factors Ⅷ Company Revenue Ranking in 2025
  2. 3.2 Global Clotting Factors Ⅷ Revenue by Company (2021-2026)
  3. 3.3 Global Clotting Factors Ⅷ Sales Volume by Company (2021-2026)
  4. 3.4 Global Clotting Factors Ⅷ Average Price by Company (2021-2026)
  5. 3.5 Global Clotting Factors Ⅷ Company Ranking (2024-2026)
  6. 3.6 Global Clotting Factors Ⅷ Company Manufacturing Base and Headquarters
  7. 3.7 Global Clotting Factors Ⅷ Company Product Type and Application
  8. 3.8 Global Clotting Factors Ⅷ Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Clotting Factors Ⅷ Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Clotting Factors Ⅷ Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Clotting Factors Ⅷ Market by Type
  1. 4.1 Clotting Factors Ⅷ Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Freeze-dried Injection
  4. 4.2 Global Clotting Factors Ⅷ Sales Volume by Type
  5. 4.2.1 Global Clotting Factors Ⅷ Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Clotting Factors Ⅷ Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Clotting Factors Ⅷ Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Clotting Factors Ⅷ Sales Value by Type
  9. 4.3.1 Global Clotting Factors Ⅷ Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Clotting Factors Ⅷ Sales Value by Type (2021-2032)
  11. 4.3.3 Global Clotting Factors Ⅷ Sales Value Share by Type (2021-2032)
5 Clotting Factors Ⅷ Market by Application
  1. 5.1 Clotting Factors Ⅷ Application Introduction
  2. 5.1.1 Hemophilia A
  3. 5.1.2 Bleeding Diseases
  4. 5.2 Global Clotting Factors Ⅷ Sales Volume by Application
  5. 5.2.1 Global Clotting Factors Ⅷ Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Clotting Factors Ⅷ Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Clotting Factors Ⅷ Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Clotting Factors Ⅷ Sales Value by Application
  9. 5.3.1 Global Clotting Factors Ⅷ Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Clotting Factors Ⅷ Sales Value by Application (2021-2032)
  11. 5.3.3 Global Clotting Factors Ⅷ Sales Value Share by Application (2021-2032)
6 Clotting Factors Ⅷ Regional Sales and Value Analysis
  1. 6.1 Global Clotting Factors Ⅷ Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Clotting Factors Ⅷ Sales by Region (2021-2032)
  3. 6.2.1 Global Clotting Factors Ⅷ Sales by Region: 2021-2026
  4. 6.2.2 Global Clotting Factors Ⅷ Sales by Region (2027-2032)
  5. 6.3 Global Clotting Factors Ⅷ Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Clotting Factors Ⅷ Sales Value by Region (2021-2032)
  7. 6.4.1 Global Clotting Factors Ⅷ Sales Value by Region: 2021-2026
  8. 6.4.2 Global Clotting Factors Ⅷ Sales Value by Region (2027-2032)
  9. 6.5 Global Clotting Factors Ⅷ Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Clotting Factors Ⅷ Sales Value (2021-2032)
  12. 6.6.2 North America Clotting Factors Ⅷ Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Clotting Factors Ⅷ Sales Value (2021-2032)
  15. 6.7.2 Europe Clotting Factors Ⅷ Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Clotting Factors Ⅷ Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Clotting Factors Ⅷ Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Clotting Factors Ⅷ Sales Value (2021-2032)
  21. 6.9.2 South America Clotting Factors Ⅷ Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Clotting Factors Ⅷ Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Clotting Factors Ⅷ Sales Value Share by Country, 2025 VS 2032
7 Clotting Factors Ⅷ Country-level Sales and Value Analysis
  1. 7.1 Global Clotting Factors Ⅷ Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Clotting Factors Ⅷ Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Clotting Factors Ⅷ Sales by Country (2021-2032)
  4. 7.3.1 Global Clotting Factors Ⅷ Sales by Country (2021-2026)
  5. 7.3.2 Global Clotting Factors Ⅷ Sales by Country (2027-2032)
  6. 7.4 Global Clotting Factors Ⅷ Sales Value by Country (2021-2032)
  7. 7.4.1 Global Clotting Factors Ⅷ Sales Value by Country (2021-2026)
  8. 7.4.2 Global Clotting Factors Ⅷ Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Clotting Factors Ⅷ Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Clotting Factors Ⅷ Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Clotting Factors Ⅷ Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Taibang Biological
  2. 8.1.1 Taibang Biological Company Information
  3. 8.1.2 Taibang Biological Business Overview
  4. 8.1.3 Taibang Biological Clotting Factors Ⅷ Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Taibang Biological Clotting Factors Ⅷ Product Portfolio
  6. 8.1.5 Taibang Biological Recent Developments
  7. 8.2 Shanghai Laishi
  8. 8.2.1 Shanghai Laishi Company Information
  9. 8.2.2 Shanghai Laishi Business Overview
  10. 8.2.3 Shanghai Laishi Clotting Factors Ⅷ Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Laishi Clotting Factors Ⅷ Product Portfolio
  12. 8.2.5 Shanghai Laishi Recent Developments
  13. 8.3 Lvshizi
  14. 8.3.1 Lvshizi Company Information
  15. 8.3.2 Lvshizi Business Overview
  16. 8.3.3 Lvshizi Clotting Factors Ⅷ Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lvshizi Clotting Factors Ⅷ Product Portfolio
  18. 8.3.5 Lvshizi Recent Developments
  19. 8.4 Hualan Biological
  20. 8.4.1 Hualan Biological Company Information
  21. 8.4.2 Hualan Biological Business Overview
  22. 8.4.3 Hualan Biological Clotting Factors Ⅷ Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hualan Biological Clotting Factors Ⅷ Product Portfolio
  24. 8.4.5 Hualan Biological Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Clotting Factors Ⅷ Value Chain Analysis
  2. 9.1.1 Clotting Factors Ⅷ Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Clotting Factors Ⅷ Sales Mode & Process
  6. 9.2 Clotting Factors Ⅷ Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Clotting Factors Ⅷ Distributors
  9. 9.2.3 Clotting Factors Ⅷ Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst